CINECA IRIS Institutional Research Information System

BIOLATTI, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.224
EU - Europa 2.870
AS - Asia 1.448
AF - Africa 89
SA - Sud America 61
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.745
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.145
IT - Italia 1.176
CN - Cina 506
IE - Irlanda 343
SG - Singapore 285
SE - Svezia 261
DE - Germania 218
GB - Regno Unito 193
JP - Giappone 131
FR - Francia 126
AT - Austria 105
VN - Vietnam 94
UA - Ucraina 92
IN - India 82
FI - Finlandia 81
KR - Corea 79
HK - Hong Kong 68
CA - Canada 55
PL - Polonia 47
AU - Australia 42
BE - Belgio 38
NL - Olanda 36
TR - Turchia 33
IR - Iran 30
SN - Senegal 29
IQ - Iraq 27
GR - Grecia 26
IL - Israele 24
SA - Arabia Saudita 24
TW - Taiwan 23
ES - Italia 21
BR - Brasile 20
MX - Messico 20
PK - Pakistan 20
DK - Danimarca 19
UG - Uganda 18
RU - Federazione Russa 17
ZA - Sudafrica 16
CO - Colombia 13
NO - Norvegia 12
CH - Svizzera 11
NZ - Nuova Zelanda 10
RO - Romania 10
SI - Slovenia 10
PH - Filippine 9
TN - Tunisia 9
AR - Argentina 8
HR - Croazia 7
PE - Perù 7
EC - Ecuador 5
CL - Cile 4
NG - Nigeria 4
PR - Porto Rico 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
LU - Lussemburgo 3
MA - Marocco 3
PT - Portogallo 3
TH - Thailandia 3
ZM - Zambia 3
BD - Bangladesh 2
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GY - Guiana 2
ID - Indonesia 2
MY - Malesia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
GH - Ghana 1
IS - Islanda 1
JO - Giordania 1
LB - Libano 1
MU - Mauritius 1
NP - Nepal 1
UY - Uruguay 1
YE - Yemen 1
Totale 8.745
Salva come PNG Salva come JPEG
Città #
Chandler 849
Dublin 336
Singapore 214
Torino 205
Fairfield 180
Beijing 170
Ann Arbor 133
Ashburn 127
Houston 120
Woodbridge 116
Sovicille 115
Nyköping 114
Turin 108
Redwood City 100
Vienna 98
Jacksonville 91
Wilmington 85
Cambridge 81
Princeton 81
Medford 72
Pisa 70
Seattle 70
Dong Ket 65
Dearborn 62
Guangzhou 60
Villeurbanne 59
Los Angeles 47
Boston 46
Rome 46
Fremont 43
Warsaw 36
Milan 35
Santa Clara 34
Washington 33
New York 32
Norwalk 26
Higashiayase 25
Tokyo 25
Hebei 24
Shanghai 23
Maddaloni 22
San Diego 22
Boardman 21
Rochester 21
Taipei 21
Nanjing 20
Pittsburgh 20
Helsinki 19
Munich 19
Kampala 18
Lappeenranta 17
Birmingham 16
Brussels 16
Florence 16
San Mauro Torinese 16
Wuhan 16
Elk Grove Village 15
Gongju 15
Jeddah 15
Hangzhou 14
Seoul 14
Thebes 14
Toronto 14
Aarhus 13
Ipswich 13
Sulaymaniyah 13
Bogotá 12
Hanover 12
Hefei 12
London 12
Piemonte 12
Central 11
Melbourne 11
Philadelphia 11
San Mateo 11
Berlin 10
Blackwood 10
Cardiff 10
Dallas 10
Frankfurt am Main 10
Istanbul 10
Baltimore 9
Casteggio 9
Chicago 9
Hamburg 9
Johannesburg 9
Lincoln 9
Ottawa 9
Utrecht 9
Boffalora sopra Ticino 8
Brescia 8
Changsha 8
Fossano 8
Kunming 8
Leeds 8
Novara 8
Padova 8
Tel Aviv 8
West Point 8
Bethesda 7
Totale 5.019
Salva come PNG Salva come JPEG
Nome #
The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion 367
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 317
Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children. [*Dell'Oste V, *Landolfo S, co-corresponding authors] 270
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 228
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 217
PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. 201
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 177
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 177
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 177
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 176
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 170
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability [*Biolatti M, *Dell'Oste V, co-first authors] 165
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 157
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 157
Genotypic analysis of HCMV polymorphism in congenital infections to predict the impact of HCMV disease severity in newborns/infants 155
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 145
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 140
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 129
Evasion strategy of Human Cytomegalovirus from the antiviral activities of APOBEC3G 129
Strigolactone analogs are promising antiviral agents against Herpesviruses 127
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 121
Past and ongoing adaptation of human cytomegalovirus to its host. 121
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 119
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease. 118
Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability 114
A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits. 114
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 113
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 108
Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity 106
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 105
Where do we stand after decades of studying human cytomegalovirus? 103
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 102
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 102
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 102
A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation 99
COMPARATIVE ANALYSIS OF HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATES FROM KIDNEY TRANSPLANT RECIPIENTS 98
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis 98
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 95
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 94
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 88
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 88
Evasion Strategy of Human Cytomegalovirus to Escape Interferon-β-Induced APOBEC3G Editing Activity 86
Human Cytomegalovirus and Autoimmune Diseases: Where Are We? 85
HCMV TEGUMENT PROTEINS: NEW INSIGHTS ON INTERACTION BETWEEN THE DNA SENSOR PROTEIN IFI16 AND VIRION PARTICLES 84
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. 84
Tuning the Orchestra: HCMV vs. Innate Immunity. 83
Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses [*Valentina Dell'Oste, Daniele Castagnolo: co-corresponding authors] 81
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 79
Risk of Symptomatic Infection after Non-Primary Congenital Cytomegalovirus Infection 79
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 78
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 78
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability 76
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 75
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting the main protease Mpro 74
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 74
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 71
PAD2 FOR USE IN DIAGNOSING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY AND INHIBITORS OR ANTAGONISTS OF PAD2 FOR USE AS ANTI-VIRAL AGENTS AGAINST VIRUSES OF THE HERPESVIRIDAE FAMILY 69
Peptidyl Arginine Deiminases: a Novel Antiviral Target against Human Cytomegalovirus 68
SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity 68
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 67
PYHIN Proteins and HPV: Role in the Pathogenesis of Head and Neck Squamous Cell Carcinoma 65
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 65
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 64
Metabolic games: IFI16-driven regulation of cellular metabolism upon HCMV infection 60
Targeting PAD-mediated citrullination to treat human papillomavirus infections 60
45th International Herpesvirus Workshop 60
Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ 57
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 57
Strigolactones as broad-spectrum antivirals against ß-coronaviruses through targeting the main protease Mpro 54
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 54
STRIGOLACTONES FOR USE IN PREVENTING AND/OR TREATING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY 53
Strigolactone analogs are promising antiviral agents for the treatment of human cytomegalovirus infection 52
THE GENETIC VARIABILITY OF HUMAN CITOMEGALOVIRUS: POSSIBLE IMPLICATIONS IN CLINICAL, IMMUNOLOGICAL AND VIROLOGICAL SETTINGS 52
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 51
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting SARS-CoV-2 Mpro 46
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection 46
50° Congresso Nazionale della Società Italiana di Microbiologia 44
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 43
Targeting PAD-mediated citrullination to treat human papillomavirus infections 43
CONGENITAL CYTOEGALOVIRUS INFECTION: CAN THE DIFFERENCE BETWEEN THE VIRUS’ RELATIONSHIP WITH THE HOST’S IMMUNE SYSTEM EXPLAIN THE DIFFERENCE IN CLINICAL PHENOTYPES? 42
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 42
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 40
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 34
La variabilità genetica del citomegalovirus umano: possibili implicazioni dal punto di vista clinico, immunologico e virologico 32
Citrullination upon viral infection: a new strategy for host-targeting antivirals drugs 30
IFI16 Impacts Metabolic Reprogramming During Human Cytomegalovirus Infection 29
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 28
Investigating PAD-mediated citrullination in HPV-driven head and neck squamous cell carcinoma 23
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro 22
Interplay between HCMV Protein pp65 and cGAS-STING Pathway: Modulating Viral Infectivity via Lipid Metabolism 22
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease 21
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors 21
HERPES SIMPLEX VIRUS TYPE 1 EXPLOITS LIPID METABOLISM: IMPLICATIONS FOR VIRAL INFECTIVITY AND ALZHEIMER’S DISEASE 19
The Impact of Fatty Acid Synthase on HSV-1 Infectivity Unveils the Key Interconnection with Alzheimer’s Disease 17
Replication properties and immunomodulatory effects of human cytomegalovirus infection impact the clinical presentation in congenital patients: A case series [*Valentina Dell'Oste: corresponding author] 16
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum [*Valentina Dell'Oste, Marco Blangetti co-corresponding authors; † Greta Bajetto, Davide Arnodo co-first authors] 16
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 15
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 11
Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs 11
Herpesvirus-mediated protein citrullination as a new target for antiviral therapy 10
Totale 8.975
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.783
article - articoli 0
book - libri 0
conference - conferenze 15.448
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.231
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020813 0 0 52 102 38 110 91 68 77 104 71 100
2020/20211.166 72 69 66 58 97 118 132 75 84 152 67 176
2021/20221.294 75 71 91 128 70 54 61 69 45 92 324 214
2022/20232.390 130 143 56 279 255 537 118 211 323 71 138 129
2023/20241.350 167 164 95 62 122 161 100 92 24 102 95 166
2024/2025535 109 311 115 0 0 0 0 0 0 0 0 0
Totale 9.016